Acuamark Diagnostics Secures $11.3 Million Series A Funding To Advance Innovative Assays For Improved, Cost-Effective Early-Cancer Detection
Acuamark Diagnostics Secures $11.3 Million Series A Funding To Advance Innovative Assays For Improved, Cost-Effective Early-Cancer Detection
07/20/22, 1:04 PM
Location
new yorkMoney raised
$11.3 million
Industry
healthcare
Round Type
series a
Acuamark Diagnostics ("AcuamarkDx"), an early cancer detection company, today announced the closing of an $11.3 million Series A round.
Company Info
Location
101 avenue of the americas
new york, new york, united states
Additional Info
Acuamark Diagnostics develops technology to allow for highly accurate screening of blood to detect cancer markers at the early cancer stages, before the cancer becomes untreatable. Backed by a highly experienced scientific team, it is Acuamark Diagnostics' mission to contribute to the global battle against cancer by detecting and attacking cancer through high-precision, early detection.